Internal Medicine, Endocrinology, Diabetes, & Metabolism · Savannah, GA
NPI
1629155676
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
340 Eisenhower Dr, 1600
Savannah, GA, 31406
Phone (912) 355-6029
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
4,939 services
Medicare patients, 2024
513
Average age 72
Drug cost, 2024
$3.2M
7,062 prescriptions
Company payments, 2025
$1,033
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas G Gresham was code 99214 (office e&m - established), 667 times for 371 patients. In total Douglas G Gresham billed 4,939 services in 48 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 667 | 371 | $80.22 | $54K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 592 | 341 | $11.43 | $6,768 |
| 36415 Venipuncture Blood Collection | Office | 403 | 259 | $8.53 | $3,438 |
| 84439 Clinical Chemistry | Office | 222 | 158 | $8.84 | $1,962 |
| 84443 Clinical Chemistry | Office | 220 | 157 | $16.46 | $3,621 |
| 83036 Blood Count | Office | 167 | 107 | $9.42 | $1,574 |
| 99204 Office E&M - New | Office | 130 | 130 | $107.77 | $14K |
| 80053 Clinical Chemistry | Office | 115 | 99 | $10.35 | $1,190 |
| 99205 Office E&M - New | Office | 71 | 71 | $150.83 | $11K |
| 85025 Blood Count | Office | 53 | 50 | $7.61 | $403 |
| 84481 Clinical Chemistry | Office | 51 | 37 | $16.60 | $847 |
| 99215 Office E&M - Established | Office | 49 | 43 | $118.13 | $5,788 |
| 80061 Clinical Chemistry | Office | 38 | 34 | $13.12 | $499 |
| 82306 Clinical Chemistry | Office | 28 | 27 | $29.01 | $812 |
| 84403 Clinical Chemistry | Office | 21 | 19 | $25.29 | $531 |
By year: 2022 $73K for 1,789 services; 2023 $105K for 3,744 services; 2024 $135K for 4,939 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 403 | 259 | $8.53 | $3,438 |
| 84439 Clinical Chemistry | 222 | 158 | $8.84 | $1,962 |
| 84443 Clinical Chemistry | 220 | 157 | $16.46 | $3,621 |
| 83036 Blood Count | 167 | 107 | $9.42 | $1,574 |
| 80053 Clinical Chemistry | 115 | 99 | $10.35 | $1,190 |
| 85025 Blood Count | 53 | 50 | $7.61 | $403 |
| 84481 Clinical Chemistry | 51 | 37 | $16.60 | $847 |
| 80061 Clinical Chemistry | 38 | 34 | $13.12 | $499 |
| 82306 Clinical Chemistry | 28 | 27 | $29.01 | $812 |
| 84403 Clinical Chemistry | 21 | 19 | $25.29 | $531 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas G Gresham prescribed most often to Medicare patients was Levothyroxine Sodium, with 564 prescriptions and refills. In total Douglas G Gresham wrote 7,062 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 564 | 1,617 | 183 | $7,303 |
| Ozempic Semaglutide | 499 | 885 | 129 | $820K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 394 | 849 | 128 | $67K |
| Mounjaro Tirzepatide | 253 | 348 | 47 | $361K |
| Tresiba Flextouch U-100 Insulin Degludec | 241 | 531 | 74 | $211K |
| Metformin Hcl Er Metformin Hcl | 234 | 690 | 89 | $1,920 |
| Novolog Flexpen Insulin Aspart | 220 | 457 | 84 | $48K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 211 | 537 | 101 | $28K |
| Humalog Kwikpen U-100 Insulin Lispro | 190 | 392 | 63 | $50K |
| Methimazole Generic | 174 | 441 | 55 | $2,355 |
| Synthroid Levothyroxine Sodium | 171 | 379 | 40 | $15K |
| Metformin Hcl Generic | 154 | 420 | 49 | $1,172 |
| Glimepiride Generic | 131 | 371 | 44 | $902 |
| Farxiga Dapagliflozin Propanediol | 118 | 252 | 35 | $140K |
| Trulicity Dulaglutide | 116 | 173 | 23 | $169K |
Brand drugs: 3,778 claims; generic drugs: 2,600 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas G Gresham $1,033 ($1,033 in general payments such as food, travel and fees) from 14 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $222.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $222 |
| Novo Nordisk Inc NVO | 17 | $221 |
| Insulet Corporation PODD | 8 | $135 |
| Calliditas Therapeutics US Inc. | 5 | $104 |
| Mallinckrodt Hospital Products Inc. | 4 | $83.27 |
| Averitas Pharma Inc. | 3 | $69.16 |
| OPKO Pharmaceuticals, LLC | 2 | $45.23 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $32.85 |
| CeQur Corporation | 1 | $25 |
| Travere Therapeutics, Inc. TVTX | 1 | $22.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.